Jones S L, Headrick E G
NAACOGS Clin Issu Perinat Womens Health Nurs. 1992;3(2):301-12.
Assisted reproductive technologies (ART) have moved from the experimental periphery of clinical treatment to the center of routine practice in the field of reproductive endocrinology. With advances in technology, reduced operative risks, increasing third party reimbursement and increased accessibility to ART programs, a more heterogeneous group of couples is seeking these services. The traditional ART couple has been joined by a growing number of couples who are at risk for or affected by a genetic disorder. These individuals seek alternative methods of conception to minimize the risk of conceiving a child with a significant birth defect. Programs offering donor gamete, donor embryo, gestational carrier, and in the future, preimplantation genetic testing must be prepared for the unique needs of the "traditional" infertile and "nontraditional" fertile couple.
辅助生殖技术（ART）已从临床治疗的实验边缘领域发展到生殖内分泌学常规实践的核心领域。随着技术进步、手术风险降低、第三方报销增加以及ART项目的可及性提高，越来越多不同类型的夫妇开始寻求这些服务。除了传统的ART夫妇，越来越多有遗传疾病风险或受其影响的夫妇也加入其中。这些人寻求替代受孕方法，以尽量降低生育出有严重出生缺陷孩子的风险。提供供体配子、供体胚胎、代孕载体服务的项目，以及未来提供植入前基因检测服务的项目，必须为“传统”不育夫妇和“非传统”可育夫妇的独特需求做好准备。
